The International Society for Biopharmaceutical Statistics (ISBS) is pleased to announce the 8th International Symposium on Biopharmaceutical Statistics, taking place from 13 to 16 October 2026, at Novotel Madrid Center, Madrid, Spain.

This scientific conference will convene statisticians and quantitative scientists to explore cutting-edge methodologies and their application across the entire biomedical product lifecycle, with a theme of Evidence Insights – Statistical Innovation, Regulatory Science, and the Transformative Impact of AI in Biopharma. Join us to address key challenges and opportunities in biomedical product development and post-approval management within the modern regulatory landscape.

Key symposium topics include (but are not limited to):

• Drug Discovery & Development: Preclinical research, PK/PD, early development, CMC, and clinical trials;
• Real-World Evidence & Safety: RWD/RWE, pharmacovigilance, pharmacoepidemiology, and outcomes research;
• Advanced Methodologies: Pharmacogenomics, innovative trial designs, advancement of statistical modeling and analyses, computation, and simulation;
• Regulatory Science: Innovative tools, standards, methods, and approaches to assess the safety, efficacy, quality, and performance of biomedical products;
• Health Technology Assessment (HTA) and Economic Evaluation: HTA requirements, joint clinical assessments, evidence synthesis, and health economic evaluation; and
• Artificial Intelligence (AI)/Machine Learning (ML) and Digital Technologies: Integration of AI/ML and DT into modern biomedical product development — real-world examples, best practices, challenges, and outlook.